Summary
This 8-K filing from Johnson & Johnson details the outcomes of its 2021 Annual Meeting of Shareholders held on April 22, 2021. The primary focus for investors is the shareholder voting results on key governance and compensation matters. Notably, all 14 director nominees were overwhelmingly elected to the Board of Directors, and shareholders approved, on an advisory basis, the company's executive compensation practices. Additionally, PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for fiscal year 2021, indicating continued confidence in the company's financial oversight. The filing also outlines several shareholder proposals that did not receive majority approval. These include proposals requesting a report on government financial support and COVID-19 vaccine access, an independent board chair, a civil rights audit, and executive compensation bonus deferral. The significant rejection of these proposals suggests that the current board structure, executive compensation policies, and governance practices align with the majority shareholder sentiment, although the presence of substantial dissenting votes on some proposals warrants continued monitoring by investors.
Key Highlights
- 1All 14 director nominees were successfully elected to the Johnson & Johnson Board of Directors.
- 2Shareholders approved, on an advisory basis, the executive compensation philosophy, policies, and procedures.
- 3PricewaterhouseCoopers LLP was ratified as the company's independent registered public accounting firm for fiscal year 2021.
- 4A shareholder proposal requesting a report on government financial support and access to COVID-19 vaccines and therapeutics was not approved.
- 5A shareholder proposal advocating for an independent board chair did not receive majority support.
- 6A shareholder proposal for a civil rights audit was not approved by shareholders.
- 7A shareholder proposal for executive compensation bonus deferral was also not approved.